Neuroactivity of the naturally occurring aporphine alkaloid, roemerine

  • Nat Prod Res. 2021 Dec;35(24):6147-6152. doi: 10.1080/14786419.2020.1830395.
Omer Bayazeid  1 Emirhan Nemutlu  2 Cemil Can Eylem  2 Mert İlhan  3 Esra Küpeli-Akkol  3 Hande Karahan  4 Pelin Kelicen-Uğur  4 Tayfun Ersoz  5 Funda N Yalçın  1
Affiliations
  • 1. Faculty of Pharmacy, Department of Pharmacognosy, Hacettepe University, Sihhiye, Ankara, Turkey.
  • 2. Faculty of Pharmacy, Department of Analytical Chemistry, Hacettepe University, Sihhiye, Ankara, Turkey.
  • 3. Faculty of Pharmacy, Department of Pharmacognosy, Gazi University, Ankara, Turkey.
  • 4. Faculty of Pharmacy, Department of Pharmacology, Hacettepe University, Sihhiye, Ankara, Turkey.
  • 5. Faculty of Pharmacy, European University of Lefke, Lefke, Turkey.
Abstract

Roemerine is a naturally occurring aporphine alkaloid. In this study, we screened a conformer library of Food and Drug Administration (FDA)-approved drugs to identify similar drugs that can assist in identifying the biological targets of roemerine. To assess the neuroactivity in vitro, we measured the levels of cell metabolites, Brain-Derived Neurotrophic Factor (BDNF) and serotonin (5-HT) in SH-SY5Y cell line. By means of structure-based virtual screening, we identified five drugs that are similar to roemerine; mirtazapine, atomoxetine, epinastine, diphenhydramine and orphenadrine. GC-MS metabolomics study revealed that roemerine has a high impact on alanine-aspartate-glutamate pathway in cell lysate and cultured medium. Additionally, roemerine increased intercellular 5-HT level and intracellular BDNF protein expression at 10 µM. In conclusion, roemerine - a major alkaloid in antidepressant-like effect possessing Plants (P. lacerum and P. syriacum) - has a neuronal activity through increasing BDNF protein expression and affecting serotonergic and glutamatergic systems in SH-SY5Y cell line.

Keywords
BDNF; Metabolomics; Papaver; alkaloid; in silico.
Products